BioPhorum Development Group

Our goal is to improve the development process of biopharmaceutical medicines for patients. Through the unique collaboration, members have a safe space to share solutions and best practices on emerging industry trends, technologies and issues. All while protecting intellectual property and confidentiality. Creating enhanced product quality while reducing time and budget, BioPhorum Development Group gives your organization a competitive edge when bringing products to market.

Are you ready to become a member? Make an enquiry today.

Join 35 of the top pharma companies to help bring biopharma products to market quicker with enhanced patient safety and reduced regulatory risks. Collaborate with therapy developers and contract manufacturing organizations to share knowledge and develop best practices for the industry.


BioPhorum Development Group has two themes which inform our work: to reduce product development lead times and exploit new technologies.

Our members tackle the industry challenges through three strategic workstreams which focus on key areas.

Speed to First-in-Human

By listening to what is most important for our member companies, we can focus on pressing industry perspectives to bring about change.

The Phorum’s major benchmarking survey is a significant benefit that considered both technical practices and the impact of how Covid-19 accelerated work.

The survey brought about a paper which emphasizes that it is possible to make safe and efficacious products quicker than is currently accepted, that will benefit everyone, including patients, the industry, and all associated stakeholders.

Accelerating CMC Development

We know that through accelerated development principles we can bring products to market at speed, often for less work. Plus, these principles can benefit many other workstreams in the industry.

To meet this need for using prior knowledge, we have developed a tool which captures references to articles or journals cited in filing applications. This will build a repository of prior knowledge to help make future filing applications more robust and justify any of the stories and data they have put forward from an organizational perspective.

Host Cell Proteins

Our work on Host Cell Proteins (HCP) has established BioPhorum as a key player in the HCP community.

Our paper and associated database have led to the development of higher quality, purer products.

Now the industry wants the database populated with more information. Therefore, demonstrating a real need for the database from host cell protein experts with input across disciplines like regulatory, process engineers, toxicologists and immunologists.

Our 150+ community will see our BioPhorum Development Group members leverage the power of its many experts to lead in this field.

The ability to collaborate with 26 different companies through BioPhorum was very powerful and resulted in a meaningful publication, which provides a list of frequently seen HCPs all in one place… The specific list of high-risk HCPs that companies should be aware of is a very helpful resource and we hope the online database on BioPhorum’s website will be a useful resource for years to come.
Marisa Jones
Analytical Science & Technology Lead, GSK

Contact BioPhorum Development Group

To find out more about how BioPhorum BioPhorum Development Group can help your business, enter your details below and a member of our team will be in touch.

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Inaugural BioPhorum Quality face to face – get involved
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing